H.R. 6321

Summary

H.R. 6321, the Lung Cancer Medicare Access to Precise Testing Act, was introduced in the House on Nov 28, 2025 by Rep. Josh Gottheimer (D) with 3 co-sponsors. It was referred to Energy And Commerce, and last saw action on Nov 28, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Record

Text

H.R. 6321 has 3 co-sponsors.

119 HR 6321 IH: Lung Cancer Medicare Access to Precise Testing Act
 U.S. House of Representatives
 2025-11-28
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 6321  IN THE HOUSE OF REPRESENTATIVES   November 28, 2025   Mr. Gottheimer  (for himself and  Mrs. Kiggans of Virginia ) introduced the following bill; which was referred to the  Committee on Energy and Commerce , and in addition to the Committee on  Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned   A BILL
To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
1.
Short title
This Act may be cited as the   Lung Cancer Medicare Access to Precise Testing Act  .
2.
Requiring coverage of lung cancer biomarker testing under Medicare
(a)
Coverage
Section 1861 of the Social Security Act ( 42 U.S.C. 1395x ) is amended—
(1)
in subsection (s)(2)—
(A)
in subparagraph (JJ), by adding  and  at the end; and
(B)
by adding at the end the following new subparagraph:
(KK)
lung cancer biomarker testing (as defined in subsection (nnn));
 ; and
(2)
by adding at the end the following new subsection:
(nnn)
Lung cancer biomarker testing
The term  lung cancer biomarker testing  means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) based on the analysis of such individual’s tissue, blood, or bodily fluids.
 .
(b)
Payment
Section 1833(a)(1) of the Social Security Act ( 42 U.S.C. 1395y(a)(1) ) is amended—
(1)
by striking  and (HH)  and inserting  (HH) ; and
(2)
by inserting  , and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing  before the semicolon at the end.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.

Sponsors

Rep. Josh Gottheimer (D) sponsors H.R. 6321, and 3 members have co-sponsored it, 1 of them from the day it was introduced.

Josh Gottheimer

Rep. · D–NJ-5 · Sponsor

Introduced Nov 28, 2025

Jennifer Kiggans

Rep. · R–VA-2 · Co-sponsor

Joined Nov 28, 2025 · Original

Eric Swalwell

Rep. · D–CA-14 · Co-sponsor

Joined Dec 15, 2025

Adelita Grijalva

Rep. · D–AZ-7 · Co-sponsor

Joined Feb 3, 2026

Show 4 of 4 rows

PreviousNext

Committees

H.R. 6321 went before 2 committees: Ways and Means and Energy and Commerce.

Ways and Means

Ways and Means

Referred To · Nov 28, 2025 · 1,160 Bills

Energy and Commerce

Energy and Commerce

Referred To · Nov 28, 2025 · 1,636 Bills

Actions

H.R. 6321 has taken 2 actions since Nov 28, 2025.

Votes

H.R. 6321 has not gone to a roll call.

Titles

H.R. 6321 goes by 3 titles, 1 of them short titles.

• Lung Cancer Medicare Access to Precise Testing Act — Display Title
• Lung Cancer Medicare Access to Precise Testing Act — Short Title(s) as Introduced
• To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 9 registered lobbyists who named H.R. 6321 in 4 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Defense, Taxation/Internal Revenue Code, Budget/Appropriations, Clean Air and Water (quality), Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Tobacco.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 6321 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 6321’s is Health.

Source: congress.gov · legiscan.com